Alliance Clinical Network, backed by Amulet Capital, merges with Atlas Clinical Research

  • Alliance Clinical Network closed its merger with Atlas Clinical Research, creating a combined clinical trial site network across seven US states.
  • Anthony Milonas will lead the combined company as CEO, with headquarters in Southlake, Texas.
  • The deal broadens therapeutic coverage and is aimed at improving trial recruitment speed, execution consistency, and access to diverse patient populations.
  • Amulet Capital Partners and BPOC will continue to back the combined platform.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amulet Capital Partners LP published the original content used to generate this news brief on June 02, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.